Modulation of Cardiometabolic Risk by Vitamin D and K2: Simple Supplementation or Real Drug? Uncovering the Pharmacological Properties
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms27010298 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Saverio D'Elia und 14 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Unit, University Hospital Luigi Vanvitelli, 80138 Naples, Italy. Hauptthemen laut MEDLINE: Vitamin D, Dietary Supplements, Vitamin K 2, Cardiovascular Diseases. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Vitamin D, traditionally regarded as a nutrient, is increasingly recognized as a pharmacologically active secosteroid with pleiotropic effects extending beyond calcium homeostasis and bone integrity. Together with vitamin K2, it participates in the fine-tuning of mineral metabolism and vascular health, potentially modulating cardiometabolic risk through intertwined endocrine and paracrine pathways. Despite widespread fortification and supplementation, vitamin D deficiency remains a major global health concern, driven by limited sun exposure, obesity, and metabolic dysfunction. Observational and mechanistic studies consistently link low serum 25(OH)D concentrations with hypertension, insulin resistance, heart failure, and increased cardiovascular mortality. At the molecular level, vitamin D exerts pharmacological actions—modulating the renin–angiotensin–aldosterone system, exerting anti-inflammatory and antifibrotic effects, and influencing endothelial and cardiomyocyte signaling. While experimental and epidemiological evidence suggests potential cardiovascular benefits, large randomized controlled trials (RCTs) provide conflicting results, particularly regarding hypertension and heart failure. However, these often-neutral results do not preclude a targeted action. On the contrary, clinical efficacy is strongly dependent on baseline deficiency status and the presence of metabolic cofactors. In this context, high-dose supplementation of Vitamin D, in combination with Vitamin K2 to prevent vascular calcification, elevates the supplement to a genuine pharmacological agent, with a distinct therapeutic potential for modulating cardiometabolic risk in selected patient subgroups. Emerging evidence supports the concept that vitamin D, when appropriately dosed and combined with K2, may act more as a low-potency pharmacological modulator than a simple nutritional supplement. This review synthesizes current mechanistic, observational, and interventional evidence, aiming to clarify whether vitamin D should be reclassified—from a micronutrient to a pharmacologically relevant agent—in cardiometabolic prevention and therapy, proposing a paradigm shift toward personalized and targeted dosing strategies, characteristic of precision pharmacology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiology Unit, University Hospital Luigi Vanvitelli, 80138 Naples, Italy.
- Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Piazza Luigi Miraglia, 2, 80138 Naples, Italy.
- Department of Public Health, University of Naples "Federico II", 80131 Naples, Italy.
- Department of Translational Medical Sciences, Section of Cardiology, University of Campania Luigi Vanvitelli, 80131 Naples, Italy.
- Vanvitelli Cardiology and Intensive Care Unit, Monaldi Hospital, 80131 Naples, Italy.
- Department of Life Science, Health, and Health Professions, Link Campus University, 00165 Rome, Italy.
ORCID-Profile: Saverio D'Elia, Roberta Bottino, Andreina Carbone, Mariarosaria Morello, Gisella Titolo, Francesco Natale, Plinio Cirillo, Giovanni Cimmino
Zitieren
APA
D'Elia, S., Bottino, R., Carbone, A., Formisano, T., Orlandi, M., Sperlongano, S., Castaldo, P., Molinari, D., Palladino, A., Morello, M., Titolo, G., Loffredo, F. S., Natale, F., Cirillo, P., & Cimmino, G. (2025). Modulation of Cardiometabolic Risk by Vitamin D and K2: Simple Supplementation or Real Drug? Uncovering the Pharmacological Properties. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010298
Vancouver
D'Elia S, Bottino R, Carbone A, Formisano T, Orlandi M, Sperlongano S, et al. Modulation of Cardiometabolic Risk by Vitamin D and K2: Simple Supplementation or Real Drug? Uncovering the Pharmacological Properties. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010298
BibTeX
@article{DElia2025,
author = {D'Elia, Saverio and Bottino, Roberta and Carbone, Andreina and Formisano, Tiziana and Orlandi, Massimiliano and Sperlongano, Simona and Castaldo, Pasquale and Molinari, Daniele and Palladino, Alberto and Morello, Mariarosaria and Titolo, Gisella and Loffredo, Francesco S and Natale, Francesco and Cirillo, Plinio and Cimmino, Giovanni},
title = {Modulation of Cardiometabolic Risk by Vitamin D and K2: Simple Supplementation or Real Drug? Uncovering the Pharmacological Properties},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms27010298}
}
EUVIMED